Granite Point Capital Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Granite Point Capital Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,857	Closed	-$504K	–	150
2018 Q1	$504K	Buy	2,857 +2,643	+1,235%	+$884K	0.05%	83
2017 Q4	$78K	Hold	214	–	–	0.01%	97
2017 Q3	$123K	Hold	214	–	–	0.03%	96
2017 Q2	$212K	Hold	214	–	–	0.05%	94
2017 Q1	$285K	Buy	+214	New	+$258K	0.09%	75

Other funds holding ZSAN

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Granite Point Capital Management's ZSAN Position: Q2 2018 in Review

Granite Point Capital Management sold out of Zosano Pharma Corporation (ZSAN) in Q2 2018, closing a stake of 2,857 shares — an estimated $504K sold.

Granite Point Capital Management first reported a position in ZSAN in Q1 2017 and held it in 5 quarters. The position peaked at $504K in Q1 2018. 25 funds tracked by Wall St. Rank hold ZSAN as of Q2 2018.

Granite Point Capital Management reported no remaining Zosano Pharma Corporation position as of Q2 2018 after selling out during the quarter.
Granite Point Capital Management sold 2,857 Zosano Pharma Corporation shares in Q2 2018, an estimated $504K.
Granite Point Capital Management first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 5 quarters.
Granite Point Capital Management's Zosano Pharma Corporation position peaked at $504K in Q1 2018.
25 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2018.

Based on Granite Point Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.